Regression results for modeling VKA daily dose requirements based on age and genotype according to drug type
| Model variable . | Warfarin . | Phenprocoumon . | ||
|---|---|---|---|---|
| P . | R2 for model, % . | P . | R2 for model, % . | |
| Age | .0006 | 31.2 | .0086 | 25.5 |
| VKORC1 | .63 | 2.8 | .17 | 10.8 |
| CYP2C9 | .69 | 0.5 | .75 | 0.3 |
| Age, VKORC1, CYP2C9 | .0025 | 34 | .04 | 35.5 |
| Model variable . | Warfarin . | Phenprocoumon . | ||
|---|---|---|---|---|
| P . | R2 for model, % . | P . | R2 for model, % . | |
| Age | .0006 | 31.2 | .0086 | 25.5 |
| VKORC1 | .63 | 2.8 | .17 | 10.8 |
| CYP2C9 | .69 | 0.5 | .75 | 0.3 |
| Age, VKORC1, CYP2C9 | .0025 | 34 | .04 | 35.5 |